JUN 10, 2019 8:44 AM PDT

New discovery sheds light for precision medicine in cancer

A recent study published in Cancer Research highlights findings of a molecular indicator that could provide a new way for doctors to help predict how patients will respond to certain anticancer drugs. The research comes from scientists at Université de Montreal and could pave the way for novel methods of precision medicine.

The molecular indicator is composed of a group of enzymes called SRC kinases, which work to chemically modify a tumor-suppressing protein called SOCS1.

"SOCS1 is part of a gene-regulation circuit centered around the master cell proliferation regulator p53, often called the guardian of the genome," said senior author Gerardo Ferbeyre, a biochemist from Université de Montreal. "If p53 or another protein in its network is mutated or becomes chemically modified in some abnormal way, a pattern of gene activation occurs that programs cells to proliferate without control, as occurs in cancers."

This may sound complex (it is), but what it means is that the authors discovered another way in which p53 can become unbalanced, which results in the proliferation of cancer cells. This discovery will help predict if an anticancer drug could be an effective treatment for a patient’s tumor.

Subburaj Ilangumaran, a Université de Sherbrooke biochemist on the study, explained: "This new mechanism for SOCS1 inactivation may actually represent a regulatory control that is hijacked by cancer cells. On a more fundamental level, our group's discovery -- that phosphorylation of SOCS1 acquires a new physical form -- opens the door to hitherto unknown ways of regulating SOCS1 functions. And this has implications for the treatment of autoimmune diseases and for anticancer immunity."

This discovery could pave the way for new methods of precision medicine in cancer. Photo: Pixabay

UdeM PhD student Emmanuelle Saint-Germain added, "We were able to detect phosphorylated SOCS1 in patients' samples with an antibody that we developed. The same antibody could be used to detect phosphorylated SOCS1 in a clinical setting, providing a way to decide whether SRC kinase inhibitors would be an effective treatment."

Sources: Science Daily, Cancer Research

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JUL 23, 2021
Cancer
Repurposed Antibiotics Show Promise Against Skin Cancer
JUL 23, 2021
Repurposed Antibiotics Show Promise Against Skin Cancer
In experiments with mice, researchers from the Netherlands have found that some antibiotics may be effective in tre ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
SEP 18, 2021
Genetics & Genomics
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
SEP 18, 2021
Cancer Genes Might Aim for the Immune System, Not Growth Promotion
The DNA in our cells can accumulate damage over may years. Environmental influences like UV light or cigarette smoke may ...
SEP 30, 2021
Cancer
Gut Microbiota Influences Colon Cancer Development
SEP 30, 2021
Gut Microbiota Influences Colon Cancer Development
The gut microbiome consists of all the microorganisms living in an individual’s digestive system. Various factors ...
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 14, 2021
Clinical & Molecular DX
Weighing Cancer Cells Helps Predict Treatment Outcomes
OCT 14, 2021
Weighing Cancer Cells Helps Predict Treatment Outcomes
Not all cancer patients respond to oncology treatments in the same way. Some might show signs of improvement as the ther ...
Loading Comments...